Teemu Suna is the CEO and one of the founders of Nightingale Health Ltd, a Finnish biotech company reinventing global medical research and healthcare for chronic diseases through use of its pioneering blood analysis service. Standing at the helm of a major success story in the Finnish startup community, Suna has transformed Nightingale into an established growth company with over 60 employees in less than four years.
He is an experienced speaker, regularly invited to prominent thought-leadership and government-hosted events. Suna has over 15 years of experience in engineering and management positions, having previously served as Chief Technology Officer at Fujitsu Finland. As a passionate advocate for visionary healthcare solutions, Suna leads Nightingale on its mission to solve the global burden of chronic diseases, empowering people to follow-up on their own health and take actions to stay healthy. Under Suna’s leadership, Nightingale has raised more than 20M€ in funding since Sept 2015.
Notice: This person is attending Slush or has done so in the past. Description last updated Sep 11, 2018